S&P 500   2,991.54 (-0.21%)
DOW   26,848.56 (-0.66%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
NFLX   275.98 (-5.92%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
S&P 500   2,991.54 (-0.21%)
DOW   26,848.56 (-0.66%)
QQQ   192.03 (-0.79%)
AAPL   236.13 (+0.36%)
FB   185.92 (-2.35%)
MSFT   138.05 (-1.17%)
GOOGL   1,245.66 (-0.57%)
AMZN   1,763.32 (-1.35%)
CGC   20.00 (-3.66%)
MU   43.47 (-4.46%)
BABA   170.36 (-3.67%)
TSLA   256.90 (-1.94%)
AMD   30.81 (-1.06%)
T   38.23 (+1.08%)
F   9.29 (+1.98%)
NFLX   275.98 (-5.92%)
BAC   30.45 (+0.63%)
GILD   64.23 (-1.53%)
Log in

Nevro News Headlines (NYSE:NVRO)

$85.18
-0.23 (-0.27 %)
(As of 10/18/2019 02:26 PM ET)
Today's Range
$84.61
Now: $85.18
$86.09
50-Day Range
$76.86
MA: $85.00
$90.36
52-Week Range
$34.75
Now: $85.18
$91.60
Volume4,648 shs
Average Volume330,721 shs
Market Capitalization$2.63 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.21

Headlines

Nevro (NYSE NVRO) News Headlines

Source:
DateHeadline
Nevro Corp (NYSE:NVRO) Expected to Post Quarterly Sales of $93.65 MillionNevro Corp (NYSE:NVRO) Expected to Post Quarterly Sales of $93.65 Million
www.americanbankingnews.com - October 17 at 4:11 AM
Nevro Corp (NYSE:NVRO) Short Interest UpdateNevro Corp (NYSE:NVRO) Short Interest Update
www.americanbankingnews.com - October 16 at 6:52 PM
Svb Leerink Weighs in on Nevro Corps FY2021 Earnings (NYSE:NVRO)Svb Leerink Weighs in on Nevro Corp's FY2021 Earnings (NYSE:NVRO)
www.americanbankingnews.com - October 16 at 7:14 AM
Nevro Corp (NYSE:NVRO) Expected to Announce Earnings of -$0.81 Per ShareNevro Corp (NYSE:NVRO) Expected to Announce Earnings of -$0.81 Per Share
www.americanbankingnews.com - October 15 at 3:20 PM
­Nevro to Report Third Quarter 2019 Financial Results - Yahoo Finance­Nevro to Report Third Quarter 2019 Financial Results - Yahoo Finance
finance.yahoo.com - October 10 at 5:58 PM
­Nevro to Report Third Quarter 2019 Financial Results­Nevro to Report Third Quarter 2019 Financial Results
finance.yahoo.com - October 10 at 7:58 AM
Nevro (NYSE:NVRO) Stock Rating Reaffirmed by Wells Fargo & CoNevro (NYSE:NVRO) Stock Rating Reaffirmed by Wells Fargo & Co
www.americanbankingnews.com - October 9 at 7:51 AM
Nevro Corp (NYSE:NVRO) Receives Average Rating of "Hold" from BrokeragesNevro Corp (NYSE:NVRO) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - October 6 at 9:31 AM
SentinelOne Appoints Divya Ghatak as Chief People Officer and Raj Rajamani as Chief Product Officer - Yahoo FinanceSentinelOne Appoints Divya Ghatak as Chief People Officer and Raj Rajamani as Chief Product Officer - Yahoo Finance
finance.yahoo.com - September 30 at 5:02 PM
Nevro Corp (NYSE:NVRO) Expected to Announce Quarterly Sales of $93.65 MillionNevro Corp (NYSE:NVRO) Expected to Announce Quarterly Sales of $93.65 Million
www.americanbankingnews.com - September 24 at 2:59 AM
Heres Why You Should Hold on to Nevro (NVRO) Stock for NowHere's Why You Should Hold on to Nevro (NVRO) Stock for Now
www.msn.com - September 23 at 8:46 PM
Heres Why You Should Hold on to Nevro (NVRO) Stock for Now - Yahoo FinanceHere's Why You Should Hold on to Nevro (NVRO) Stock for Now - Yahoo Finance
finance.yahoo.com - September 23 at 3:46 PM
Here's Why You Should Hold on to Nevro (NVRO) Stock for NowHere's Why You Should Hold on to Nevro (NVRO) Stock for Now
finance.yahoo.com - September 23 at 3:46 PM
Global $13Bn+ Neurosurgery Devices Market by Product, Application and Region - Forecast to 2024 - ResearchAndMarkets.com - BenzingaGlobal $13Bn+ Neurosurgery Devices Market by Product, Application and Region - Forecast to 2024 - ResearchAndMarkets.com - Benzinga
www.benzinga.com - September 19 at 1:06 PM
Why Is Nevro (NVRO) Up 37.7% Since Last Earnings Report?Why Is Nevro (NVRO) Up 37.7% Since Last Earnings Report?
finance.yahoo.com - September 7 at 12:29 PM
Nevro Announces Completion of Patient Enrollment in Largest Multicenter Randomized Controlled Trial of High Frequency Spinal Cord Stimulation for Painful Diabetic Neuropathy - PRNewswireNevro Announces Completion of Patient Enrollment in Largest Multicenter Randomized Controlled Trial of High Frequency Spinal Cord Stimulation for Painful Diabetic Neuropathy - PRNewswire
www.prnewswire.com - August 28 at 1:01 PM
Nevro Announces Completion of Patient Enrollment in Largest Multicenter Randomized Controlled Trial of High Frequency Spinal Cord Stimulation for Painful Diabetic NeuropathyNevro Announces Completion of Patient Enrollment in Largest Multicenter Randomized Controlled Trial of High Frequency Spinal Cord Stimulation for Painful Diabetic Neuropathy
finance.yahoo.com - August 28 at 1:01 PM
Nevro to Present at Morgan Stanley 17th Annual Healthcare ConferenceNevro to Present at Morgan Stanley 17th Annual Healthcare Conference
finance.yahoo.com - August 23 at 7:38 AM
Heres Why You Should Retain Nevro (NVRO) in Your Portfolio - NasdaqHere's Why You Should Retain Nevro (NVRO) in Your Portfolio - Nasdaq
www.nasdaq.com - August 21 at 5:41 AM
Global Neurostimulation Devices Market Forecast (2019-2026) Featuring Key Players Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, and Nevro - ResearchAndMarkets.com - Yahoo FinanceGlobal Neurostimulation Devices Market Forecast (2019-2026) Featuring Key Players Medtronic, St. Jude Medical, Boston Scientific, Cyberonics, and Nevro - ResearchAndMarkets.com - Yahoo Finance
finance.yahoo.com - August 20 at 11:44 AM
Heres Why You Should Retain Nevro (NVRO) in Your Portfolio - Yahoo FinanceHere's Why You Should Retain Nevro (NVRO) in Your Portfolio - Yahoo Finance
finance.yahoo.com - August 19 at 7:15 PM
Health Check: How Prudently Does Nevro (NYSE:NVRO) Use Debt? - Yahoo FinanceHealth Check: How Prudently Does Nevro (NYSE:NVRO) Use Debt? - Yahoo Finance
finance.yahoo.com - August 15 at 6:35 PM
Health Check: How Prudently Does Nevro (NYSE:NVRO) Use Debt?Health Check: How Prudently Does Nevro (NYSE:NVRO) Use Debt?
finance.yahoo.com - August 15 at 6:35 PM
Nevro (NVRO) Catches Eye: Stock Jumps 6.3% - Yahoo FinanceNevro (NVRO) Catches Eye: Stock Jumps 6.3% - Yahoo Finance
finance.yahoo.com - August 14 at 7:00 PM
Nevro Corp (NVRO) Q2 2019 Earnings Call Transcript - NasdaqNevro Corp (NVRO) Q2 2019 Earnings Call Transcript - Nasdaq
www.nasdaq.com - August 11 at 9:56 AM
Nevro Corp (NVRO) Q2 2019 Earnings Call TranscriptNevro Corp (NVRO) Q2 2019 Earnings Call Transcript
www.fool.com - August 10 at 3:53 AM
Nevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y - Yahoo FinanceNevro (NVRO) Q2 Loss Wider Than Expected, Revenues Down Y/Y - Yahoo Finance
finance.yahoo.com - August 9 at 7:45 PM
Edited Transcript of NVRO earnings conference call or presentation 8-Aug-19 8:30pm GMT - Yahoo FinanceEdited Transcript of NVRO earnings conference call or presentation 8-Aug-19 8:30pm GMT - Yahoo Finance
finance.yahoo.com - August 9 at 8:07 AM
Edited Transcript of NVRO earnings conference call or presentation 8-Aug-19 8:30pm GMTEdited Transcript of NVRO earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 9 at 8:07 AM
Nevro Reports Second Quarter 2019 Financial Results - PRNewswireNevro Reports Second Quarter 2019 Financial Results - PRNewswire
www.prnewswire.com - August 9 at 12:44 AM
Nevro EPS beats by $0.06, beats on revenueNevro EPS beats by $0.06, beats on revenue
seekingalpha.com - August 8 at 7:42 PM
Nevro Reports Second Quarter 2019 Financial ResultsNevro Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 8 at 7:42 PM
Nevro Q2 2019 Earnings Preview - Seeking AlphaNevro Q2 2019 Earnings Preview - Seeking Alpha
seekingalpha.com - August 8 at 5:58 AM
Pain Management Devices Market to Witness 9.4% CAGR; Boston Scientific’s ‘Spectra WaveWriter’ Launch to Enable Growth, says Fortune Business Insights - Yahoo FinancePain Management Devices Market to Witness 9.4% CAGR; Boston Scientific’s ‘Spectra WaveWriter’ Launch to Enable Growth, says Fortune Business Insights - Yahoo Finance
finance.yahoo.com - August 6 at 5:05 AM
Earnings Preview: Nevro (NVRO) Q2 Earnings Expected to Decline - Yahoo FinanceEarnings Preview: Nevro (NVRO) Q2 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - August 3 at 5:53 PM
Earnings Preview: Nevro (NVRO) Q2 Earnings Expected to Decline - NasdaqEarnings Preview: Nevro (NVRO) Q2 Earnings Expected to Decline - Nasdaq
www.nasdaq.com - August 1 at 7:34 PM
Earnings Preview: Nevro (NVRO) Q2 Earnings Expected to DeclineEarnings Preview: Nevro (NVRO) Q2 Earnings Expected to Decline
finance.yahoo.com - August 1 at 7:34 PM
Nevro Announces Court Order Granting Preliminary Injunction Against Stimwave Technologies, Inc.Nevro Announces Court Order Granting Preliminary Injunction Against Stimwave Technologies, Inc.
finance.yahoo.com - July 25 at 8:35 AM
­Nevro to Report Second Quarter 2019 Financial Results - Yahoo Finance­Nevro to Report Second Quarter 2019 Financial Results - Yahoo Finance
finance.yahoo.com - July 16 at 9:27 AM
­Nevro to Report Second Quarter 2019 Financial Results­Nevro to Report Second Quarter 2019 Financial Results
finance.yahoo.com - July 15 at 6:03 PM
Pain Management Devices Market Growth Factors & Competitive Analysis, 2019-2028 | Key Players: Medtronic, St. Jude Medical, Smiths Medical, Stryker Corporation, Nevro Corp., Halyard Health, Hospira (Pfizer), & Neurotech: Radiant Insights, Inc. - PRNewswirePain Management Devices Market Growth Factors & Competitive Analysis, 2019-2028 | Key Players: Medtronic, St. Jude Medical, Smiths Medical, Stryker Corporation, Nevro Corp., Halyard Health, Hospira (Pfizer), & Neurotech: Radiant Insights, Inc. - PRNewswire
www.prnewswire.com - July 3 at 9:11 AM
Heres Why You Should Hold on to Nevro (NVRO) Stock Now - Yahoo FinanceHere's Why You Should Hold on to Nevro (NVRO) Stock Now - Yahoo Finance
finance.yahoo.com - July 2 at 5:57 PM
Pain Management Devices Market Growth Factors & Competitive Analysis, 2019-2028 | Key Players: Medtronic, St. Jude Medical, Smiths Medical, Stryker Corporation, Nevro Corp., Halyard Health, Hospira (Pfizer), & Neurotech: Radiant Insights, Inc. - Yahoo FinancePain Management Devices Market Growth Factors & Competitive Analysis, 2019-2028 | Key Players: Medtronic, St. Jude Medical, Smiths Medical, Stryker Corporation, Nevro Corp., Halyard Health, Hospira (Pfizer), & Neurotech: Radiant Insights, Inc. - Yahoo Finance
finance.yahoo.com - July 2 at 9:09 AM
Patents hint at breakthroughs for med tech companies Nevro, Genomic Health and Omnicell - Silicon Valley - Silicon Valley Business JournalPatents hint at breakthroughs for med tech companies Nevro, Genomic Health and Omnicell - Silicon Valley - Silicon Valley Business Journal
www.bizjournals.com - June 28 at 9:06 AM
Nevro Announces Executive Appointments - PRNewswireNevro Announces Executive Appointments - PRNewswire
www.prnewswire.com - June 25 at 6:37 PM
Nevro expands leadership team - Seeking AlphaNevro expands leadership team - Seeking Alpha
seekingalpha.com - June 25 at 10:50 AM
Nevro Announces Executive AppointmentsNevro Announces Executive Appointments
finance.yahoo.com - June 25 at 10:50 AM
14.7% of VHT Holdings Seeing Recent Insider Buys - Nasdaq14.7% of VHT Holdings Seeing Recent Insider Buys - Nasdaq
www.nasdaq.com - June 21 at 11:28 AM
Nevro Corp. (NYSE:NVRO) Insiders Increased Their Holdings - Yahoo FinanceNevro Corp. (NYSE:NVRO) Insiders Increased Their Holdings - Yahoo Finance
finance.yahoo.com - June 21 at 11:28 AM
Nevro Corp. (NYSE:NVRO) Insiders Increased Their HoldingsNevro Corp. (NYSE:NVRO) Insiders Increased Their Holdings
finance.yahoo.com - June 21 at 11:28 AM
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: What is Compound Interest?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel